Drug-Metabolizing Enzyme Polymorphisms Predict Clinical Outcome in a Node-Positive Breast Cancer Cohort - Concepedia

Concepedia

Publication | Closed Access

Drug-Metabolizing Enzyme Polymorphisms Predict Clinical Outcome in a Node-Positive Breast Cancer Cohort

55

Citations

36

References

2005

Year

Angela DeMichele, Richard Aplenc, Jeffrey Botbyl, Theresa Colligan, Lisa Wray, Melissa Klein-Cabral, Andrea S. Foulkes, Phyllis A. Gimotty, John H. Glick, Barbara Weber,

Journal of Clinical Oncology

Abstract

Combined genotypes at CYP3A4, CYP3A5, GSTM1, and GSTT1 influence the probability of treatment failure after high-dose adjuvant chemotherapy for node-positive breast cancer.

References

	Year	Citations

Page 1